Scilex Holding Co
SCLXW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $16.4K in total; no superinvestor holds it.
Other share classesSCLX
Q2 2023 vs. Q1 2023
How the institutions holding Scilex Holding Co changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 10 | 10 | 0 |
| Shares | 403.0K | 171.7K | −231.3K (−57.4%) |
| Value | $1.49M | $237.7K | −$1.26M (−84.1%) |
New holders (3)
Institutions that held Scilex Holding Co at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Clear Street LLC | 2,480 | $3.45K | 0.00% |
| UBS Group AG | 1,273 | $1.77K | 0.00% |
| Elequin Capital LP | 1,000 | $1.39K | 0.00% |
Sold out (3)
Institutions that held Scilex Holding Co at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| LMR Partners LLP | 150,000 | $1.23M |
| Wolverine Asset Management LLC | 51,736 | $54.3K |
| Affinity Asset Advisors, LLC | 18,099 | $19.0K |